COMPLEX REHABILITATION OF ISCHEMIC HEART DISEASE PATIENTS AFTER CORONARY BYPASS OPERATION WITH THE USE OF BIOLOGICALLY ACTIVE SUPPLEMENTS

Authors

DOI:

https://doi.org/10.32782/pub.health.2023.3.16

Keywords:

ischemic heart disease, dihydroquercetin, biologically active supplements

Abstract

Chronic deficiency of essential trace elements in the diet of a person nowadays against the background of disturbances in the structure of nutrition, hypo dynamism, adverse environmental factors, and other adverse effects of civilization is associated with the occurrence of general diseases and leads to a decrease in the duration of working capacity and unjustified socio-economic losses. Available domestic and international experiences show that the problem of optimizing nutrition, including the special products containing biologically active additives (BAA), with a targeted systemic effect, convincingly indicate a successful solution through national health problems. Overcoming the consequences of surgical intervention, prevention, and treatment of early and late postoperative complications largely determine the effectiveness of the entire complex of rehabilitation measures. The purpose of the work was to study the possibility of using Dihydroquercetin in rehabilitation programs for patients with coronary artery disease after Coronary artery bypass grafting (CABG) surgery in order to increase the effectiveness of rehabilitation, which has notable scientific and practical significance. The methodological basis of the research is based on systemic, historical, terminological, and informational approaches. The results of the study showed the high clinical effectiveness of Taxifolin in the complex medical rehabilitation of patients with coronary artery disease who underwent the operation. The pills intake did not affect indicators of carbohydrate and lipid metabolism, which indicates its metabolic neutrality. None of the patients had any worsening of the condition, nor increased frequency of angina attacks, nor episodes of painless ischemia. All patients indicated good tolerability of the drug, and improvement in general well-being (reduction or disappearance of shortness of breath, decrease in pain intensity, increase in activity, improvement in sleep). The implementation of the optimized rehabilitation program also contributed to the improvement of the psycho-emotional state of the patients. Conclusion. Сomplex medical rehabilitation of patients with coronary heart disease after Coronary artery bypass grafting surgery according to a program with the inclusion of Dihydroquercetin (Taxifolin) helps to improve the rheological properties of blood, strengthen the active vasomotor mechanisms of MC regulation, improve indicators of central and peripheral hemodynamics, blood oxygenation, increase in exercise tolerance, improve psycho-emotional the condition, which ultimately ensure an increase in the rehabilitation effect.

References

Drogovoz, S., Kalko, K., Borysiuk, I., Barus, M., Horoshko, V., Svyshch, O., & Liulchak, S. (2021). Potential risks and pharmacological safety features of hypoglycemic drugs.

Al Namat, R., Al Namat, D., Ciocoiu, M., Hinganu, MV, Eurodoc, L., Eurorod, V., ... & Felea, M. (2022). H-FABP Levels and Psycho-Emotional Improvement of CABG Patients в период Cardiac Rehabilitation. Journal of Cardiovascular Development and Disease , 9(8), 242.

Dragan, S., Buleu, F., Christodorescu, R., Cobzariu, F., Iurciuc, S., Velimirovici, D., ... & Luca, CT (2019). Benefits of multiple micronutrient supplementation in heart failure: A comprehensive review. Critical reviews in food science and nutrition , 59(6), 965–981.

Zang, L. (2021). Nanoparticles in the diagnosis and treatment of coronary artery diseases under sports rehabilitation in tervention. Ferroelectrics, 580(1), 283–297.

Cicero, A. F., Colletti, A., von Haehling, S., Vinereanu, D., Bielecka-Dabrowa, A., Sahebkar, A., ... & Banach, M. (2020). Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP). Nutrition research reviews, 33(1), 155–179.

Sharifi-Rad, J., Rodrigues, C. F., Sharopov, F., Docea, A. O., Can Karaca, A., Sharifi-Rad, M., ... & Calina, D. (2020). Diet, lifestyle and cardiovascular diseases: linking pathophysiology to cardioprotective effects of natural bioactive compounds. International journal of environmental research and public health, 17(7), 2326.

Lerner, R. K., Gruber, N., & Pollak, U. (2019). Congenital heart disease and thyroid dysfunction: combination, association, and implication. World Journal for Pediatric and Congenital Heart Surgery, 10(5), 604–615.

Members, WC, Lawton, JS, Tamis-Holland, JE, Bangalore, S., Bates, ER, Beckie, TM, ... & Zwischenberger, BA (2022). 2021 ACC/AHA/SCAI guideline для коронарной архитектуры реvascularization: report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of American College of Cardiology , 79 (2), e21-e129.

Baltatu, O. C., Senar, S., Campos, L. A., & Cipolla-Neto, J. (2019). Cardioprotective melatonin: translating from proof-of-concept studies to therapeutic use. International Journal of Molecular Sciences, 20(18), 4342.

Marin, W., Marin, D., Ao, X., & Liu, Y. (2021). Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury. International Journal of Molecular Medicine, 47(2), 485–499.

Published

2023-08-25

Issue

Section

Статті